Results 41 to 50 of about 54,214 (96)

Personalised pulmonary rehabilitation in COPD

open access: yesEuropean Respiratory Review, 2018
This review summarises ongoing developments in personalised medicine and individualised medicine in chronic obstructive pulmonary disease (COPD). Currently applied classification systems largely ignore the complexity and heterogeneity of the COPD ...
Emiel F.M. Wouters   +5 more
doaj   +1 more source

T2 and T17 cytokines alter the cargo and function of airway epithelium-derived extracellular vesicles

open access: yesRespiratory Research, 2020
Background Asthma is a common and heterogeneous disease that includes subgroups characterized by type 2 (T2) or type 17 (T17) immune responses for which there is a need to identify the underlying mechanisms and biomarkers in order to develop specific ...
Elisabeth Ax   +6 more
doaj   +1 more source

A retrospective analysis of treatment patterns, overall survival, and real-world disease-free survival in early-stage non-small cell lung cancer following complete resection

open access: yesBMC Pulmonary Medicine
Background Real-world data regarding patient characteristics, adjuvant treatment patterns, and long-term survival outcomes are needed to better understand unmet needs among patients with completely resected early-stage non-small cell lung cancer (NSCLC).
Xiaohan Hu   +6 more
doaj   +1 more source

Eosinophilic airway inflammation and eosinophilic chronic rhinosinusitis during nivolumab and ipilimumab

open access: yesRespirology Case Reports, 2020
Immune‐related adverse events (irAEs) are induced by immune checkpoint inhibitors (ICIs) which are administered for many cancers. There are many irAEs such as endocrine abnormalities, interstitial lung disease, and colitis. However, irAEs associated with
Hirofumi Watanabe   +5 more
doaj   +1 more source

A grand mimicker of pulmonary malignancy: The massive mediastinal intercostal nerve tumour

open access: yesRespirology Case Reports
Mediastinal mass‐like manifestations often cause alarm and instigate a myriad of investigative testing to rule out insidious malignant processes. However, a unique and benign finding, the schwannoma can present either incidentally or while in pursuit of ...
Syed H. Haq   +6 more
doaj   +1 more source

Dietary ω-6 polyunsaturated fatty acid arachidonic acid increases inflammation, but inhibits ECM protein expression in COPD

open access: yesRespiratory Research, 2018
Background The obesity paradox in COPD describes protective effects of obesity on lung pathology and inflammation. However, the underlying relationships between obesity, diet and disease outcomes in COPD are not fully understood.
Sandra Rutting   +6 more
doaj   +1 more source

Association between Modifiable Risk Factors and Levels of Blood-Based Biomarkers of Alzheimer’s and Related Dementias in the Look AHEAD Cohort

open access: yesJAR life
Background Emerging evidence suggests that a number of factors can influence blood-based biomarker levels for Alzheimer’s disease (AD) and Alzheimer’s related dementias (ADRD).
K. M. Hayden   +15 more
semanticscholar   +1 more source

Comparing Costs and Healthcare Resource Utilization (HCRU) Using LAMA versus LABA/ICS at Treatment Initiation for COPD: Findings from CITRUS (Comparing the Incidence of Tiotropium and ICS/LABA in Real-World Use in South Korea) Study

open access: yesInternational Journal of COPD
Kwang Yong Choi,1 Hwan Il Kim,1 Chin Kook Rhee,2 Kwang Ha Yoo,3 Yong Bum Park,4 Youlim Kim,3 So Eun Lee,5 Jung-Ae Kim,6 Yong Il Hwang1 1Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Sacred ...
Choi KY   +8 more
doaj  

A rare case of allergic bronchopulmonary mycosis complicating pulmonary pleomorphic carcinoma

open access: yesRespirology Case Reports
A 72‐year‐old man with productive cough and wheezing was referred to our institution for a growing mass shadow and central bronchiectasis in the right lower lobe on computed tomography.
Yoshihiro Okada   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy